KIT and ovarian carcinoma: In support of the involvement of additional EMT-promoting pathways, it has been documented that c-kit activates the Wnt/β-catenin and ATP-binding cassette G2 signaling to mediate chemoresistance and tumor-initiating capacity of ovarian cancer cells [21].